210 related articles for article (PubMed ID: 8872950)
1. Biphasic glomerular hypertrophy in rats administered puromycin aminonucleoside.
Cahill MM; Ryan GB; Bertram JF
Kidney Int; 1996 Sep; 50(3):768-75. PubMed ID: 8872950
[TBL] [Abstract][Full Text] [Related]
2. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
Adamczak M; Gross ML; Amann K; Ritz E
J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
[TBL] [Abstract][Full Text] [Related]
3. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study.
Matsumae T; Fukuzaki M; Takebayashi S; Naito S
Am J Nephrol; 1998; 18(1):21-7. PubMed ID: 9481435
[TBL] [Abstract][Full Text] [Related]
4. Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture.
Nagata M; Schärer K; Kriz W
Kidney Int; 1992 Jul; 42(1):136-47. PubMed ID: 1635343
[TBL] [Abstract][Full Text] [Related]
5. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
[TBL] [Abstract][Full Text] [Related]
6. VEGF(165) mediates glomerular endothelial repair.
Ostendorf T; Kunter U; Eitner F; Loos A; Regele H; Kerjaschki D; Henninger DD; Janjic N; Floege J
J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
[TBL] [Abstract][Full Text] [Related]
7. Effects of podocyte injury on glomerular development.
Ma J; Rossini M; Yang HC; Zuo Y; Fogo AB; Ichikawa I
Pediatr Res; 2007 Oct; 62(4):417-21. PubMed ID: 17667850
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
Masuda Y; Shimizu A; Kataoka M; Arai T; Ishikawa A; Du X; Saito SK; Aki K; Nagasaka S; Mii A; Fujita E; Fukuda Y
Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
Hjalmarsson C; Lidell ME; Haraldsson B
Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
[TBL] [Abstract][Full Text] [Related]
10. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
11. [The effect of elastase on aminonucleoside nephrosis--on renal vascular system].
Ono H; Hirabayashi K; Ono Y; Sagiya A; Kanaya H; Iidaka K
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):783-8. PubMed ID: 1479717
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
Dos Santos AM; de Olveira AV; da Silva Lemos CC; Mandarim-de-Lacerda CA; Bregman R
Pathol Res Pract; 2006; 202(3):157-63. PubMed ID: 16492522
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
[TBL] [Abstract][Full Text] [Related]
14. Renal structural abnormalities following recovery from acute puromycin nephrosis.
Rasch R; Nyengaard JR; Marcussen N; Meyer TW
Kidney Int; 2002 Aug; 62(2):496-506. PubMed ID: 12110010
[TBL] [Abstract][Full Text] [Related]
15. Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.
Sagar S; Gibbons N; Valderrama E; Singhal PC
Clin Nephrol; 1995 Dec; 44(6):356-61. PubMed ID: 8719546
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
17. Differences in puromycin aminonucleoside nephrosis in two rat strains.
Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
[TBL] [Abstract][Full Text] [Related]
18. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
19. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
Fogo A; Yoshida Y; Glick AD; Homma T; Ichikawa I
J Clin Invest; 1988 Jul; 82(1):322-30. PubMed ID: 3392211
[TBL] [Abstract][Full Text] [Related]
20. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis.
Lee HS; Lim SD
Clin Nephrol; 1995 Dec; 44(6):349-55. PubMed ID: 8719545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
